34th Bethesda Conference: Task force #1--Identification of coronary heart disease risk: is there a detection gap? (Q35150514)

6 August 2017

1 reference

title

34th Bethesda Conference: Task force #1--Identification of coronary heart disease risk: is there a detection gap? (English)

1 reference

6 August 2017

1 reference

coronary artery disease

1 reference

6

Nancy Houston-Miller

1 reference

6 August 2017

3

Philip Greenland

1 reference

6 August 2017

5

Peter W F Wilson

1 reference

6 August 2017

1

Richard C Pasternak

1 reference

6 August 2017

Jonathan Abrams

2

1 reference

PubMed ID

12798553

6 August 2017

Lynn A Smaha

series ordinal

4

1 reference

PubMed ID

12798553

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Journal of the American College of Cardiology

6 August 2017

1 reference

6 August 2017

41

1 reference

6 August 2017

11

1 reference

6 August 2017

1863-1874

1 reference

Lifetime risk of developing coronary heart disease

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Primary prevention of coronary heart disease in women through diet and lifestyle

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the M

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Do conventional risk factors predict subclinical coronary artery disease? Results from the Prospective Army Coronary Calcium Project

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: Multiple Risk Factor Intervention Trial experience

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: tests for silent and inducible ischemia: Writing Group II

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Validation of exercise-enhanced risk assessment of coronary heart disease events: longitudinal changes in incidence in Seattle community practice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Exercise thallium tomography predicts future clinically manifest coronary heart disease in a high-risk asymptomatic population

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

The importance of the history in the medical clinic and the cost of unnecessary tests.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

New tools for coronary risk assessment: what are their advantages and limitations?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Problems on the pathway from risk assessment to risk reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Primary prevention of coronary heart disease: integrating risk assessment with intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Is high-sensitivity C-reactive protein an effective screening test for cardiovascular risk?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

C-reactive protein, inflammation and atherosclerosis: do we really understand it yet?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Prevention Conference V : Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Noninvasive Tests of Atherosclerotic Burden : Writing Group III

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

In-hospital initiation of lipid-lowering therapy for patients with coronary heart disease: the time is now

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Rationale and design of the Cardiac Hospitalization Atherosclerosis Management Program at the University of California Los Angeles.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900358-9

7 January 2021

10.1016/S0735-1097(03)00358-9

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12798553